Expert Opinion on Pharmacotherapy
Journal Title
- Expert Opinion on Pharmacotherapy
ISSN
- E 1744-7666 | P 1465-6566
Listed on(Coverage)
| JCR |
2005-2019 |
| SJR |
2000-2019 |
| CiteScore |
2011-2019 |
| SCIE |
2010-2021 |
| CC |
2016-2021 |
| SCOPUS |
2017-2020 |
| MEDLINE |
2016-2021 |
| EMBASE |
2016-2020 |
Aime & Scopes
- Expert Opinion on Pharmacotherapy (ISSN 1465-6566 [print], 1744-7666 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.
The Editors welcome:
/// Reviews covering new drugs/drug classes for specific diseases, from development Phase III to those that have been available to pharmacopoeia for up to 5 years, and their potential impact on future treatment strategies
/// Drug Evaluations reviewing the clinical and pharmacological data on a particular drug
/// Original Research papers reporting the results of clinical investigations on agents that are in Phase III and IV clinical trials and pharmacologically based studies with a strong link to clinical practice
The audience consists of research and development, regulatory and marketing decision makers in the pharmaceutical industry and decision makers in healthcare provision.